. Dans-le-crâne-du-nouveau-né, entre l'os frontal et les os pariétaux liés par les sutures sagittale et coronale, se trouve une membrane cartilagineuse appelée « fontanelle antérieure ». Ce cartilage est relativement souple et ne s'ossifie pas avant l'âge de 18 mois, Au cours de la palpation de la voûte crânienne à ce niveau, on peut sentir les battements cardiaques sous les doigts

N. Abelson-mitchell, Epidemiology and prevention of head injuries: literature review, Journal of Clinical Nursing, vol.29, issue.1, pp.46-57, 2008.
DOI : 10.1097/00005373-200009000-00004

H. Aguilar-mariscal, S. Patiño-camacho, J. Rodríguez-silverio, J. Torres-lópez, and F. Flores-murrieta, Oral pharmacokinetics of meloxicam in the rat using a high-performance liquid chromatographic method in micro-whole blood samples, Methods and Findings in Experimental and Clinical Pharmacology, vol.29, issue.9, pp.587-591, 2007.
DOI : 10.1358/mf.2007.29.9.1116314

M. Ahmad, M. Rose, V. Vagni, R. Griffith, C. Dixon et al., Genetic disruption of cyclooxygenase-2 does not improve histological or behavioral outcome after traumatic brain injury in mice, Journal of Neuroscience Research, vol.112, issue.16, pp.3605-3612, 2008.
DOI : 10.1002/jnr.21809

M. Ahmed, D. Khanna, and D. Furst, Meloxicam in rheumatoid arthritis, Expert Opinion on Drug Metabolism & Toxicology, vol.13, issue.2, pp.739-751, 2005.
DOI : 10.1007/PL00011190

S. Aid, A. Silva, E. Candelario-jalil, S. Choi, G. Rosenberg et al., Cyclooxygenase-1 and -2 Differentially Modulate Lipopolysaccharide-Induced Blood???Brain Barrier Disruption through Matrix Metalloproteinase Activity, Journal of Cerebral Blood Flow & Metabolism, vol.57, issue.2, pp.370-380, 2010.
DOI : 10.1111/j.1471-4159.2008.05430.x

S. Aid, R. Langenbach, and F. Bosetti, Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2, Journal of Neuroinflammation, vol.5, issue.1, p.17, 2008.
DOI : 10.1186/1742-2094-5-17

C. Albert-weissenberger and A. Sirén, Experimental traumatic brain injury, Experimental & Translational Stroke Medicine, vol.2, issue.1, p.16, 2010.
DOI : 10.1186/2040-7378-2-16

B. Anderson, Paracetamol (Acetaminophen): mechanisms of action, Pediatric Anesthesia, vol.47, issue.Suppl 1, pp.915-921, 2008.
DOI : 10.1111/j.1460-9592.2008.02764.x

G. Anderson, S. Hauser, K. Mcgarity, M. Bremer, P. Isakson et al., Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis., Journal of Clinical Investigation, vol.97, issue.11, pp.2672-2679, 1996.
DOI : 10.1172/JCI118717

T. Ashman, W. Gordon, J. Cantor, and M. Hibbard, Neurobehavioral consequences of traumatic brain injury, Mt Sinai J Med, vol.73, pp.999-1005, 2006.

H. Atta, Edwin Smith Surgical Papyrus: the oldest known surgical treatise, Am Surg, vol.65, pp.1190-1192, 1999.

D. Attwell, A. Buchan, S. Charpak, M. Lauritzen, B. Macvicar et al., Glial and neuronal control of brain blood flow, Nature, vol.15, issue.7321, pp.232-243, 2010.
DOI : 10.1038/nature09613

A. Ballinger and G. Smith, COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention, Expert Opinion on Pharmacotherapy, vol.96, issue.371, pp.31-40, 2001.
DOI : 10.1074/jbc.273.17.10095

K. Beauchamp, H. Mutlak, W. Smith, E. Shohami, and P. Stahel, Pharmacology of traumatic brain injury: where is the "golden bullet, Mol Med, vol.14, pp.731-740, 2008.

J. Bellien, R. Joannides, V. Richard, and C. Thuillez, Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: A promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?, Pharmacology & Therapeutics, vol.131, issue.1, pp.1-17, 2011.
DOI : 10.1016/j.pharmthera.2011.03.015

A. Belmont, N. Agar, C. Hugeron, B. Gallais, and P. Azouvi, Fatigue and??traumatic brain injury, Annales de R??adaptation et de M??decine Physique, vol.49, issue.6, pp.283-288, 2006.
DOI : 10.1016/j.annrmp.2006.04.018
URL : https://hal.archives-ouvertes.fr/hal-00272334

L. Beni-adani, I. Gozes, Y. Cohen, Y. Assaf, R. Steingart et al., A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice, J Pharmacol Exp Ther, vol.296, pp.57-63, 2001.

P. Bentzer, G. Mattiasson, T. Mcintosh, T. Wieloch, and P. Grande, Infusion of Prostacyclin Following Experimental Brain Injury in the Rat Reduces Cortical Lesion Volume, Journal of Neurotrauma, vol.18, issue.3, pp.275-285, 2001.
DOI : 10.1089/08977150151070919

S. Bergström, H. Danielsson, D. Klenberg, and B. Samuelsson, The enzymatic conversion of essential fatty acids into prostaglandins, J Biol Chem, vol.239, pp.4006-4008, 1964.

A. Bernareggi, Clinical Pharmacokinetics of Nimesulide, Clinical Pharmacokinetics, vol.35, issue.4, pp.247-274, 1998.
DOI : 10.2165/00003088-199835040-00001

V. Besson, X. Chen, M. Plotkine, and C. Marchand-verrecchia, Fenofibrate, a peroxisome proliferator-activated receptor ?? agonist, exerts neuroprotective effects in traumatic brain injury, Neuroscience Letters, vol.388, issue.1, pp.7-12, 2005.
DOI : 10.1016/j.neulet.2005.06.019

T. Béziaud, R. Chen, X. , E. Shafey, N. Fréchou et al., Simvastatin in traumatic brain injury: Effect on brain edema mechanisms, Critical Care Medicine, vol.39, issue.10, pp.2300-2307, 2011.
DOI : 10.1097/CCM.0b013e3182227e4a

N. Biber, H. Toklu, S. Solakoglu, M. Gultomruk, T. Hakan et al., Cysteinyl-leukotriene receptor antagonist montelukast decreases blood???brain barrier permeability but does not prevent oedema formation in traumatic brain injury, Brain Injury, vol.153, issue.6, pp.577-584, 2009.
DOI : 10.1179/016164103101201896

E. Bigler, The lesion(s) in traumatic brain injury: implications for clinical neuropsychology, Archives of Clinical Neuropsychology, vol.16, issue.2, pp.95-131, 2001.
DOI : 10.1093/arclin/16.2.95

F. Bosetti and S. Choi, Rethinking the role of cyclooxygenase-1 in neuroinflammation: More than homeostasis, Cell Cycle, vol.9, issue.15, pp.2919-2920, 2010.
DOI : 10.4161/cc.9.15.12715

R. Botting, Inhibitors of cyclooxygenases: mechanisms, selectivity and uses, J Physiol Pharmacol, vol.57, pp.113-124, 2006.

R. Botting and S. Ayoub, COX-3 and the mechanism of action of paracetamol/acetaminophen, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.72, issue.2, pp.85-87, 2005.
DOI : 10.1016/j.plefa.2004.10.005

R. Boulu, C. Gueniau, M. Plotkine, and M. Sofeir, Recovery from Global Cerebral Ischemia in Rabbits: Influence of Indomethacin, European Neurology, vol.20, issue.3, pp.230-234, 1981.
DOI : 10.1159/000115240

M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Analytical Biochemistry, vol.72, issue.1-2, pp.248-254, 1976.
DOI : 10.1016/0003-2697(76)90527-3

H. Bramlett and W. Dietrich, Pathophysiology of cerebral ischemia and brain trauma: Similarities and differences, Journal of Cerebral Blood Flow & Metabolism, vol.784, pp.133-150, 2004.
DOI : 10.1097/01.WCB.0000111614.19196.04

C. Brenneis, T. Maier, R. Schmidt, A. Hofacker, L. Zulauf et al., Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition, The FASEB Journal, vol.20, issue.9, pp.1352-1360, 2006.
DOI : 10.1096/fj.05-5346com

J. Bruns, . Jr, and W. Hauser, The Epidemiology of Traumatic Brain Injury: A Review, Epilepsia, vol.2, issue.10, pp.2-10, 2003.
DOI : 10.1046/j.1528-1157.44.s10.3.x

A. Büki and J. Povlishock, All roads lead to disconnection? ??? Traumatic axonal injury revisited, Acta Neurochirurgica, vol.1241, issue.2, pp.181-193, 2006.
DOI : 10.1007/s00701-005-0674-4

U. Busch, J. Schmid, G. Heinzel, H. Schmaus, J. Baierl et al., Pharmacokinetics of meloxicam in animals and the relevance to humans, Drug Metab Dispos, vol.26, pp.576-584, 1998.

N. Bye, M. Habgood, J. Callaway, N. Malakooti, A. Potter et al., Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration, Experimental Neurology, vol.204, issue.1, pp.220-233, 2007.
DOI : 10.1016/j.expneurol.2006.10.013

E. Candelario-jalil, A role for cyclooxygenase-1 in ??-amyloid-induced neuroinflammation, Aging, vol.1, issue.4, pp.350-353, 2009.
DOI : 10.18632/aging.100039

E. Candelario-jalil, Nimesulide as a promising neuroprotectant in brain ischemia: New experimental evidences, Pharmacological Research, vol.57, issue.4, pp.266-273, 2008.
DOI : 10.1016/j.phrs.2008.03.003

E. Candelario-jalil and B. Fiebich, Cyclooxygenase Inhibition in Ischemic Brain Injury, Current Pharmaceutical Design, vol.14, issue.14, pp.1401-1418, 2008.
DOI : 10.2174/138161208784480216

E. Candelario-jalil, A. González-falcón, M. García-cabrera, O. León, and B. Fiebich, Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats, Journal of Neurochemistry, vol.92, issue.4, pp.1108-1120, 2007.
DOI : 10.1111/j.1471-4159.2006.04280.x

E. Candelario-jalil, S. Taheri, Y. Yang, R. Sood, M. Grossetete et al., Cyclooxygenase Inhibition Limits Blood-Brain Barrier Disruption following Intracerebral Injection of Tumor Necrosis Factor-?? in the Rat, Journal of Pharmacology and Experimental Therapeutics, vol.323, issue.2, pp.488-498, 2007.
DOI : 10.1124/jpet.107.127035

E. Candelario-jalil, A. De-oliveira, S. Gräf, H. Bhatia, M. Hüll et al., Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia, Journal of Neuroinflammation, vol.4, issue.1, p.25, 2007.
DOI : 10.1186/1742-2094-4-25

E. Candelario-jalil, N. Mhadu, A. González-falcón, M. García-cabrera, E. Muñoz et al., Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat, Journal of Neuroinflammation, vol.2, issue.1, p.3, 2005.
DOI : 10.1186/1742-2094-2-3

E. Candelario-jalil, A. González-falcón, M. García-cabrera, O. León, and B. Fiebich, Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat, Brain Research, vol.1007, issue.1-2, pp.98-108, 2004.
DOI : 10.1016/j.brainres.2004.01.078

E. Candelario-jalil, A. González-falcón, M. García-cabrera, D. Alvarez, S. Al-dalain et al., Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia, Journal of Neurochemistry, vol.95, issue.3, pp.545-555, 2003.
DOI : 10.1046/j.1471-4159.2003.01812.x

E. Candelario-jalil, D. Alvarez, A. González-falcón, M. García-cabrera, G. Martínez-sánchez et al., Neuroprotective efficacy of nimesulide against hippocampal neuronal damage following transient forebrain ischemia, European Journal of Pharmacology, vol.453, issue.2-3, pp.189-195, 2002.
DOI : 10.1016/S0014-2999(02)02422-6

F. Catella-lawson, M. Reilly, S. Kapoor, A. Cucchiara, S. Demarco et al., Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin, New England Journal of Medicine, vol.345, issue.25, pp.1809-1817, 2001.
DOI : 10.1056/NEJMoa003199

D. Cederberg and P. Siesjö, What has inflammation to do with traumatic brain injury?, Child's Nervous System, vol.17, issue.2, pp.221-226, 2010.
DOI : 10.1007/s00381-009-1029-x

I. Cernak, Animal models of head trauma, NeuroRX, vol.10, issue.3, pp.410-422, 2005.
DOI : 10.1602/neurorx.2.3.410

I. Cernak, O. Connor, C. Vink, and R. , Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats, Experimental Brain Research, vol.147, issue.2, pp.193-199, 2002.
DOI : 10.1007/s00221-002-1245-z

I. Cernak, O. Connor, C. Vink, and R. , Activation Of Cyclo-Oxygenase-2 Contributes To Motor And Cognitive Dysfunction Following Diffuse Traumatic Brain Injury In Rats, Clinical and Experimental Pharmacology and Physiology, vol.10, issue.11, pp.922-925, 2001.
DOI : 10.1016/0301-0082(95)00016-O

N. Chandrasekharan and D. Simmons, The cyclooxygenases, Genome Biology, vol.5, issue.9, p.241, 2004.
DOI : 10.1186/gb-2004-5-9-241

N. Chandrasekharan, H. Dai, K. Roos, N. Evanson, J. Tomsik et al., COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression, Proceedings of the National Academy of Sciences, vol.99, issue.21, pp.13926-13931, 2002.
DOI : 10.1073/pnas.162468699

N. Chauhan, R. Gatto, and M. Chauhan, Neuroanatomical correlation of behavioral deficits in the CCI model of TBI, Journal of Neuroscience Methods, vol.190, issue.1, pp.1-9, 2010.
DOI : 10.1016/j.jneumeth.2010.04.004

X. Chen, V. Besson, T. Beziaud, M. Plotkine, and C. Marchand-leroux, Combination Therapy with Fenofibrate, a Peroxisome Proliferator-Activated Receptor ?? Agonist, and Simvastatin, a 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase Inhibitor, on Experimental Traumatic Brain Injury, Journal of Pharmacology and Experimental Therapeutics, vol.326, issue.3, pp.966-974, 2008.
DOI : 10.1124/jpet.108.140368

X. Chen, V. Besson, B. Palmier, Y. Garcia, M. Plotkine et al., Neurological Recovery-Promoting, Anti-Inflammatory, and Anti-Oxidative Effects Afforded by Fenofibrate, a PPAR Alpha Agonist, in Traumatic Brain Injury, Journal of Neurotrauma, vol.24, issue.7, pp.1119-1131, 2007.
DOI : 10.1089/neu.2006.0216

R. Chesnut, L. Marshall, M. Klauber, B. Blunt, N. Baldwin et al., THE ROLE OF SECONDARY BRAIN INJURY IN DETERMINING OUTCOME FROM SEVERE HEAD INJURY, The Journal of Trauma: Injury, Infection, and Critical Care, vol.34, issue.2, pp.216-222, 1993.
DOI : 10.1097/00005373-199302000-00006

R. Chesnut, S. Marshall, J. Piek, B. Blunt, M. Klauber et al., Early and Late Systemic Hypotension as a Frequent and Fundamental Source of Cerebral Ischemia Following Severe Brain Injury in the Traumatic Coma Data Bank, Acta Neurochir, vol.59, pp.121-125, 1993.
DOI : 10.1007/978-3-7091-9302-0_21

S. Choi and F. Bosetti, Cyclooxygenase-1 null mice show reduced neuroinflammation in response to ??-amyloid, Aging, vol.1, issue.2, pp.234-244, 2009.
DOI : 10.18632/aging.100021

S. Choi, S. Aid, and F. Bosetti, The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research, Trends in Pharmacological Sciences, vol.30, issue.4, pp.174-181, 2009.
DOI : 10.1016/j.tips.2009.01.002

S. Choi, R. Langenbach, and F. Bosetti, Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury, The FASEB Journal, vol.22, issue.5, pp.1491-1501, 2008.
DOI : 10.1096/fj.07-9411com

F. Clausen, A. Hånell, C. Israelsson, J. Hedin, T. Ebendal et al., Neutralization of interleukin-1?? reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice, European Journal of Neuroscience, vol.7, issue.Suppl 1, pp.110-123, 2011.
DOI : 10.1111/j.1460-9568.2011.07723.x

F. Clausen, A. Hånell, M. Björk, L. Hillered, A. Mir et al., Neutralization of interleukin-1?? modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice, European Journal of Neuroscience, vol.58, issue.Suppl 1, pp.385-396, 2009.
DOI : 10.1111/j.1460-9568.2009.06820.x

G. Cockerham, G. Goodrich, E. Weichel, J. Orcutt, J. Rizzo et al., Eye and visual function in traumatic brain injury, The Journal of Rehabilitation Research and Development, vol.46, issue.6, pp.811-818, 2009.
DOI : 10.1682/JRRD.2008.08.0109

J. Couzin, CLINICAL TRIALS: Halt of Celebrex Study Threatens Drug's Future, Other Trials, Science, vol.306, issue.5705, p.2170, 2004.
DOI : 10.1126/science.306.5705.2170a

J. Cracowski, F. Stanke-labesque, and G. Bessard, Isoprostanes: nouveaux marqueurs du stress oxydant. Aspects fondamentaux et cliniques, La Revue de M??decine Interne, vol.21, issue.3, pp.304-307, 2000.
DOI : 10.1016/S0248-8663(00)80056-9

P. Dash, S. Mach, and A. Moore, Regional Expression and Role of Cyclooxygenase-2 Following Experimental Traumatic Brain Injury, Journal of Neurotrauma, vol.17, issue.1, pp.69-81, 2000.
DOI : 10.1089/neu.2000.17.69

C. Degeneffe and M. Olney, ???We are the forgotten victims???: Perspectives of adult siblings of persons with traumatic brain injury, Brain Injury, vol.26, issue.12, pp.1416-1427, 2010.
DOI : 10.1080/02699050600743725

K. Deluga, F. Plötz, and A. Betz, Effect of indomethacin on edema following single and repetitive cerebral ischemia in the gerbil, Stroke, vol.22, issue.10, pp.1259-1264, 1991.
DOI : 10.1161/01.STR.22.10.1259

J. Dinchuk, R. Liu, and J. Trzaskos, COX-3: in the wrong frame in mind, Immunology Letters, vol.86, issue.1, p.121, 2003.
DOI : 10.1016/S0165-2478(02)00268-7

J. Donkin and R. Vink, Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments, Current Opinion in Neurology, vol.23, issue.3, pp.293-299, 2010.
DOI : 10.1097/WCO.0b013e328337f451

G. Engelhardt, Pharmacology of Meloxicam, A New Non-Steroidal Anti-Inflammatory Drug with an Improved Safety Profile Through Preferential Inhibition of COX-2, Rheumatology, vol.35, issue.suppl 1, pp.4-12, 1996.
DOI : 10.1093/rheumatology/35.suppl_1.4

G. Engelhardt, R. Bögel, C. Schnitzler, and R. Utzmann, Meloxican: Influence on arachidonic acid metabolism, vivo findings, pp.29-38, 1996.
DOI : 10.1016/0006-2952(95)02110-8

S. Farias, L. Frey, R. Murphy, and K. Heidenreich, Injury-Related Production of Cysteinyl Leukotrienes Contributes to Brain Damage following Experimental Traumatic Brain Injury, Journal of Neurotrauma, vol.26, issue.11, pp.1977-1986, 2009.
DOI : 10.1089/neu.2009.0877

R. Feldman and J. Goodrich, The Edwin Smith Surgical Papyrus, Child's Nervous System, vol.15, issue.6-7, pp.281-284, 1999.
DOI : 10.1007/s003810050395

M. Félétou, Y. Huang, and P. Vanhoutte, Endothelium-mediated control of vascular tone: COX-1 and COX-2 products, British Journal of Pharmacology, vol.124, issue.69, pp.894-912, 2011.
DOI : 10.1111/j.1476-5381.2011.01276.x

P. Ferguson, G. Smith, B. Wannamaker, D. Thurman, E. Pickelsimer et al., A population-based study of risk of epilepsy after hospitalization for traumatic brain injury, Epilepsia, vol.79, issue.suppl 2, pp.891-898, 2010.
DOI : 10.1111/j.1528-1167.2009.02384.x

F. Fitzpatrick and M. Wynalda, Albumin-catalyzed metabolism of prostaglandin D 2 . Identification of products formed in vitro, J Biol Chem, vol.258, pp.11713-11718, 1983.

M. Flierl, P. Stahel, K. Beauchamp, S. Morgan, W. Smith et al., Mouse closed head injury model induced by a weight-drop device, Nature Protocols, vol.20, issue.9, pp.1328-1337, 2009.
DOI : 10.1038/nprot.2009.148

A. Fortin, M. Lefebvre, and M. Ptito, Traumatic brain injury and olfactory deficits: The tale of two smell tests!, Brain Injury, vol.42, issue.1, pp.27-33, 2010.
DOI : 10.1080/0269905031000070242

R. Garavito, M. Malkowski, and D. Dewitt, The structures of prostaglandin endoperoxide H synthases-1 and -2, Prostaglandins Other Lipid Mediat, pp.68-69, 2002.

A. Gean and N. Fischbein, Head Trauma, Neuroimaging Clinics of North America, vol.20, issue.4, pp.527-556, 2010.
DOI : 10.1016/j.nic.2010.08.001

T. Geeraerts and D. Menon, Le monitorage de la pression intracr??nienne am??liore-t-il le devenir des traumatis??s cr??niens graves???, Annales Fran??aises d'Anesth??sie et de R??animation, vol.29, issue.9, pp.171-175, 2010.
DOI : 10.1016/j.annfar.2010.06.006

D. Gilroy and P. Colville-nash, New insights into the role of COX 2 in inflammation, Journal of Molecular Medicine, vol.78, issue.3, pp.121-129, 2000.
DOI : 10.1007/s001090000094

J. Giraudel, A. Diquelou, V. Laroute, P. Lees, and P. Toutain, Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat, British Journal of Pharmacology, vol.283, issue.5, pp.642-653, 2005.
DOI : 10.1007/BF01117450

M. Goncalves, E. Williams, P. Yip, R. Yáñez-muñoz, G. Williams et al., The COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain, British Journal of Pharmacology, vol.9, issue.1
DOI : 10.1111/j.1476-5381.2009.00618.x

J. Gopez, H. Yue, R. Vasudevan, A. Malik, L. Fogelsanger et al., Cyclooxygenase-2-specific Inhibitor Improves Functional Outcomes, Provides Neuroprotection, and Reduces Inflammation in a Rat Model of Traumatic Brain Injury, Neurosurgery, vol.56, issue.3, pp.590-604, 2005.
DOI : 10.1227/01.NEU.0000154060.14900.8F

J. Guay, K. Bateman, R. Gordon, J. Mancini, and D. Riendeau, Carrageenan-induced Paw Edema in Rat Elicits a Predominant Prostaglandin E2 (PGE2) Response in the Central Nervous System Associated with the Induction of Microsomal PGE2 Synthase-1, Journal of Biological Chemistry, vol.279, issue.23, pp.24866-24872, 2004.
DOI : 10.1074/jbc.M403106200

F. Guix, I. Uribesalgo, M. Coma, and F. Muñoz, The physiology and pathophysiology of nitric oxide in the brain, Progress in Neurobiology, vol.76, issue.2, pp.126-152, 2005.
DOI : 10.1016/j.pneurobio.2005.06.001

J. Haeggström and C. Funk, Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease, Chemical Reviews, vol.111, issue.10, pp.5866-5898, 2011.
DOI : 10.1021/cr200246d

T. Hakan, H. Toklu, N. Biber, H. Ozevren, S. Solakoglu et al., Effect of COX-2 inhibitor meloxicam against traumatic brain injury-induced biochemical, histopathological changes and blood???brain barrier permeability, Neurological Research, vol.147, issue.1, pp.629-635, 2010.
DOI : 10.1098/rstb.2003.1358

E. Hall, R. Vaishnav, and A. Mustafa, Antioxidant therapies for traumatic brain injury, Neurotherapeutics, vol.104, issue.suppl 2, pp.51-61, 2010.
DOI : 10.1016/j.nurt.2009.10.021

E. Hall, P. Sullivan, T. Gibson, K. Pavel, B. Thompson et al., Spatial and Temporal Characteristics of Neurodegeneration after Controlled Cortical Impact in Mice: More than a Focal Brain Injury, Journal of Neurotrauma, vol.22, issue.2, pp.252-265, 2005.
DOI : 10.1089/neu.2005.22.252

M. Hamberg, Inhibition of prostaglandin synthesis in man, Biochemical and Biophysical Research Communications, vol.49, issue.3, pp.720-726, 1972.
DOI : 10.1016/0006-291X(72)90470-6

M. Hamberg and B. Fredholm, ISomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albumin, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.431, issue.1, pp.189-193, 1976.
DOI : 10.1016/0005-2760(76)90273-3

S. Hara, D. Kamei, Y. Sasaki, A. Tanemoto, Y. Nakatani et al., Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models, Biochimie, vol.92, issue.6, pp.651-659, 2010.
DOI : 10.1016/j.biochi.2010.02.007

N. Hassan, R. Kelany, A. Emara, and M. Amer, Pattern of craniofacial injuries in patients admitted to Tanta University Hospital ??? Egypt, Journal of Forensic and Legal Medicine, vol.17, issue.1, pp.26-32, 2010.
DOI : 10.1016/j.jflm.2009.07.008

C. Hawkey, COX-2 inhibitors, The Lancet, vol.353, issue.9149, pp.307-314, 1999.
DOI : 10.1016/S0140-6736(98)12154-2

A. Hein, O. Banion, and M. , Neuroinflammation and Memory: The Role of Prostaglandins, Molecular Neurobiology, vol.22, issue.17, pp.15-32, 2009.
DOI : 10.1007/s12035-009-8066-z

F. Hellal, D. Bonnefont-rousselot, N. Croci, B. Palmier, M. Plotkine et al., Pattern of cerebral edema and hemorrhage in a mice model of diffuse brain injury, Neuroscience Letters, vol.357, issue.1, pp.21-24, 2004.
DOI : 10.1016/j.neulet.2003.12.036

F. Hellal, D. Pruneau, B. Palmier, P. Faye, N. Croci et al., Receptor in a Murine Model of Diffuse Brain Injury, Journal of Neurotrauma, vol.20, issue.9, pp.841-851, 2003.
DOI : 10.1089/089771503322385773

L. Helleberg, Clinical Pharmacokinetics of Indomethacin, Clinical Pharmacokinetics, vol.6, issue.4, pp.245-258, 1981.
DOI : 10.2165/00003088-198106040-00001

R. Helliwell, L. Adams, and M. Mitchell, Prostaglandin synthases: recent developments and a novel hypothesis, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.70, issue.2, pp.101-113, 2004.
DOI : 10.1016/j.plefa.2003.04.002

P. Hétu and D. Riendeau, Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain, Biochemical Journal, vol.391, issue.3, pp.561-566, 2005.
DOI : 10.1042/BJ20050451

R. Hickey, P. Adelson, M. Johnnides, D. Davis, Z. Yu et al., Cyclooxygenase-2 Activity Following Traumatic Brain Injury in the Developing Rat, Pediatric Research, vol.21, issue.3, pp.271-276, 2007.
DOI : 10.1203/PDR.0b013e3180db2902

G. Higgs, J. Salmon, B. Henderson, and J. Vane, Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity., Proceedings of the National Academy of Sciences, vol.84, issue.5, pp.1417-1420, 1987.
DOI : 10.1073/pnas.84.5.1417

B. Hinz and K. Brune, Cyclooxygenase-2---10 Years Later, Journal of Pharmacology and Experimental Therapeutics, vol.300, issue.2, pp.367-375, 2002.
DOI : 10.1124/jpet.300.2.367

S. Homsi, T. Piaggio, N. Croci, F. Noble, M. Plotkine et al., Blockade of Acute Microglial Activation by Minocycline Promotes Neuroprotection and Reduces Locomotor Hyperactivity after Closed Head Injury in Mice: A Twelve-Week Follow-Up Study, Journal of Neurotrauma, vol.27, issue.5, pp.911-921, 2010.
DOI : 10.1089/neu.2009.1223

S. Homsi, F. Federico, N. Croci, B. Palmier, M. Plotkine et al., Minocycline effects on cerebral edema: Relations with inflammatory and oxidative stress markers following traumatic brain injury in mice, Brain Research, vol.1291, pp.122-132, 2009.
DOI : 10.1016/j.brainres.2009.07.031

S. Hoy and L. Scott, Indomethacin/Prochlorperazine/Caffeine, CNS Drugs, vol.30, issue.1, pp.343-358, 2011.
DOI : 10.2165/11206740-000000000-00000

S. Huang, H. Ho, and C. Yang, Longitudinal outcomes of patients with traumatic brain injury: A preliminary study, Brain Injury, vol.17, issue.13-14, pp.1606-1615, 2010.
DOI : 10.1080/026990598122908

S. Hurley, J. Olschowka, O. Banion, and M. , Cyclooxygenase Inhibition as a Strategy to Ameliorate Brain Injury, Journal of Neurotrauma, vol.19, issue.1, pp.1-15, 2002.
DOI : 10.1089/089771502753460196

S. Irwin, M. Slabok, P. Debiase, and W. Govier, Perphenazine (trilafon), a new potent tranquilzer and antiemetic. I. Behavioral mode of action, Arch Int Pharmacodyn Ther, vol.118, pp.358-374, 1959.

K. Jain, Neuroprotection in traumatic brain injury, Drug Discovery Today, vol.13, issue.23-24, pp.1082-1089, 2008.
DOI : 10.1016/j.drudis.2008.09.006

M. Kelso, S. Scheff, J. Pauly, and C. Loftin, Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice, BMC Neuroscience, vol.10, issue.1, p.108, 2009.
DOI : 10.1186/1471-2202-10-108

H. Kim, J. Levasseur, J. Patterson, . Jr, G. Jackson et al., Effect of indomethacin pretreatment on acute mortality in experimental brain injury, Journal of Neurosurgery, vol.71, issue.4
DOI : 10.3171/jns.1989.71.4.0565

B. Kis, A. Snipes, F. Bari, and D. Busija, Regional distribution of cyclooxygenase-3 mRNA in the rat central nervous system, Molecular Brain Research, vol.126, issue.1, pp.78-80, 2004.
DOI : 10.1016/j.molbrainres.2004.03.015

L. Koyfman, J. Kaplanski, A. Artru, D. Talmor, M. Rubin et al., Inhibition of Cyclooxygenase 2 by Nimesulide Decreases Prostaglandin E2 Formation But Does Not Alter Brain Edema or Clinical Recovery After Closed Head Injury in Rats, Journal of Neurosurgical Anesthesiology, vol.12, issue.1, pp.44-50, 2000.
DOI : 10.1097/00008506-200001000-00009

V. Kshettry, S. Mindea, and H. Batjer, The management of cranial injuries in antiquity and beyond, Neurosurgical Focus, vol.23, issue.1, p.8, 2007.
DOI : 10.3171/FOC-07/07/E8

T. Kunz, N. Marklund, L. Hillered, and E. Oliw, Effects of the selective cyclooxygenase-2 inhibitor rofecoxib on cell death following traumatic brain injury in the rat, Restor Neurol Neurosci, vol.24, pp.55-63, 2006.

T. Kunz, N. Marklund, L. Hillered, and E. Oliw, Metabolism in Traumatic Brain Injury in the Rat, Journal of Neurotrauma, vol.19, issue.9, pp.1051-1064, 2002.
DOI : 10.1089/089771502760341965

R. Kurumbail, J. Kiefer, and L. Marnett, Cyclooxygenase enzymes: catalysis and inhibition, Current Opinion in Structural Biology, vol.11, issue.6, pp.752-760, 2001.
DOI : 10.1016/S0959-440X(01)00277-9

U. Laemmli, Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature, vol.244, issue.5259, pp.680-685, 1970.
DOI : 10.1038/227680a0

M. Laplaca, C. Simon, G. Prado, and D. Cullen, CNS injury biomechanics and experimental models, Prog Brain Res, vol.161, pp.13-26, 2007.
DOI : 10.1016/S0079-6123(06)61002-9

J. Lehmann, J. Lenhard, B. Oliver, G. Ringold, and S. Kliewer, Peroxisome Proliferator-activated Receptors ?? and ?? Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs, Journal of Biological Chemistry, vol.272, issue.6, pp.3406-3410, 1997.
DOI : 10.1074/jbc.272.6.3406

T. Lescot, R. V. , L. Manach, Y. Boroli, F. Chauvet et al., In vivo accuracy of two intraparenchymal intracranial pressure monitors, Intensive Care Medicine, vol.64, issue.Suppl 1, pp.875-879, 2011.
DOI : 10.1007/s00134-011-2182-8

T. Lescot, L. Abdennour, V. Degos, A. Boch, and L. Puybasset, R??animation des??patients traumatis??s cr??niens graves, La Presse M??dicale, vol.36, issue.7-8, pp.1117-1126, 2007.
DOI : 10.1016/j.lpm.2007.01.017

A. Lewén, P. Matz, and P. Chan, Free Radical Pathways in CNS Injury, Journal of Neurotrauma, vol.17, issue.10, pp.871-890, 2000.
DOI : 10.1089/neu.2000.17.871

W. Li, S. Wu, M. Ahmad, J. Jiang, H. Liu et al., The cyclooxygenase site, but not the peroxidase site of cyclooxygenase-2 is required for neurotoxicity in hypoxic and ischemic injury, Journal of Neurochemistry, vol.12, issue.4, pp.965-977, 2010.
DOI : 10.1111/j.1471-4159.2010.06674.x

G. Louin, C. Marchand-verrecchia, B. Palmier, M. Plotkine, and M. Jafarian-tehrani, Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury, Neuropharmacology, vol.50, issue.2, pp.182-190, 2006.
DOI : 10.1016/j.neuropharm.2005.08.020

J. Lu, S. Goh, P. Tng, Y. Deng, E. Ling et al., Systemic inflammatory response following acute traumatic brain injury, Frontiers in Bioscience, vol.Volume, issue.14, pp.3795-3813, 2009.
DOI : 10.2741/3489

C. Luh, K. Gierth, R. Timaru-kast, K. Engelhard, C. Werner et al., Influence of a Brief Episode of Anesthesia during the Induction of Experimental Brain Trauma on Secondary Brain Damage and Inflammation, PLoS ONE, vol.148, issue.5, p.19948, 2011.
DOI : 10.1371/journal.pone.0019948.t003

C. Malaplate-armand, B. Leininger-muller, and A. Batt, Les cytochromes P450 astrocytaires, une famille d???enzymes cl??s dans le m??tabolisme c??r??bral et la neuroprotection, Revue Neurologique, vol.160, issue.6-7, pp.651-658, 2004.
DOI : 10.1016/S0035-3787(04)71014-0

A. Maas, B. Roozenbeek, and G. Manley, Clinical trials in traumatic brain injury: Past experience and current developments, Neurotherapeutics, vol.334, issue.1, pp.115-126, 2010.
DOI : 10.1016/j.nurt.2009.10.022

B. Masel and D. Dewitt, Traumatic Brain Injury: A Disease Process, Not an Event, Journal of Neurotrauma, vol.27, issue.8, pp.1529-1540, 2010.
DOI : 10.1089/neu.2010.1358

C. Mésenge, C. Verrecchia, C. Charriaut-marlangue, I. Margaill, R. Boulu et al., Contribution of NO/ONOO??? pathway to the deleterious effect of traumatic brain injury in mice, Drug Discovery Today, vol.5, issue.9, pp.432-433, 2000.
DOI : 10.1016/S1359-6446(00)01554-3

C. Mésenge, I. Margaill, C. Verrecchia, M. Allix, R. Boulu et al., Protective effect of melatonin in a model of traumatic brain injury in mice, Journal of Pineal Research, vol.21, issue.1, pp.41-46, 1998.
DOI : 10.1016/0304-3940(96)12493-9

C. Mésenge, C. Charriaut-marlangue, C. Verrecchia, M. Allix, R. Boulu et al., Reduction of tyrosine nitration after N??-nitro-l-arginine-methylester treatment of mice with traumatic brain injury, European Journal of Pharmacology, vol.353, issue.1, pp.53-57, 1998.
DOI : 10.1016/S0014-2999(98)00432-4

C. Mésenge, C. Verrecchia, M. Allix, R. Boulu, and M. Plotkine, Reduction of the Neurological Deficit in Mice with Traumatic Brain Injury by Nitric Oxide Synthase Inhibitors, Journal of Neurotrauma, vol.13, issue.1, pp.209-214, 1996.
DOI : 10.1089/neu.1996.13.11

J. Meythaler, J. Peduzzi, E. Eleftheriou, and T. Novack, Current concepts: Diffuse axonal injury???associated traumatic brain injury, Archives of Physical Medicine and Rehabilitation, vol.82, issue.10, pp.1461-1471, 2001.
DOI : 10.1053/apmr.2001.25137

D. Milatovic, T. Montine, and M. Aschner, Prostanoid signaling: Dual role for prostaglandin E2 in neurotoxicity, NeuroToxicology, vol.32, issue.3, pp.312-319, 2011.
DOI : 10.1016/j.neuro.2011.02.004

S. Moncada and J. Vane, Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin, Pharmacol Rev, vol.30, pp.293-331, 1978.

M. Morganti-kossmann, E. Yan, and N. Bye, Animal models of traumatic brain injury: Is there an optimal model to reproduce human brain injury in the laboratory?, Injury, vol.41, pp.10-13, 2010.
DOI : 10.1016/j.injury.2010.03.032

M. Morganti-kossmann, L. Satgunaseelan, N. Bye, and T. Kossmann, Modulation of immune response by head injury, Injury, vol.38, issue.12, pp.1392-1400, 2007.
DOI : 10.1016/j.injury.2007.10.005

B. Morrison, K. Saatman, D. Meaney, and T. Mcintosh, Central Nervous System Models of Mechanically Induced Trauma: A Review, Journal of Neurotrauma, vol.15, issue.11, pp.911-928, 1998.
DOI : 10.1089/neu.1998.15.911

M. Murakami, I. Kudo, and A. Phospholipase, Phospholipase A2, Journal of Biochemistry, vol.131, issue.3, pp.285-292, 2002.
DOI : 10.1093/oxfordjournals.jbchem.a003101
URL : https://hal.archives-ouvertes.fr/hal-00497527

M. Murakami, H. Naraba, T. Tanioka, N. Semmyo, Y. Nakatani et al., Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2, Journal of Biological Chemistry, vol.275, issue.42, pp.32783-32792, 2000.
DOI : 10.1074/jbc.M003505200

D. Nomura, B. Morrison, J. Blankman, J. Long, S. Kinsey et al., Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation, Science, vol.334, issue.6057, pp.809-813, 2011.
DOI : 10.1126/science.1209200
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249428

G. Onyszchuk, B. Hafez, Y. He, M. Bilgen, N. Berman et al., A mouse model of sensorimotor controlled cortical impact: Characterization using longitudinal magnetic resonance imaging, behavioral assessments and histology, Journal of Neuroscience Methods, vol.160, issue.2, pp.187-196, 2007.
DOI : 10.1016/j.jneumeth.2006.09.007

E. Park, J. Bell, and A. Baker, Traumatic brain injury: Can the consequences be stopped?, Canadian Medical Association Journal, vol.178, issue.9, pp.1163-1170, 2008.
DOI : 10.1503/cmaj.080282

J. Phillis, L. Horrocks, and A. Farooqui, Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders, Brain Research Reviews, vol.52, issue.2, pp.201-243, 2006.
DOI : 10.1016/j.brainresrev.2006.02.002

J. Povlishock, R. Hayes, M. Michel, and T. Mcintosh, Workshop on Animal Models of Traumatic Brain Injury, Journal of Neurotrauma, vol.11, issue.6, pp.723-732, 1994.
DOI : 10.1089/neu.1994.11.723

O. Quraishi, J. Mancini, and D. Riendeau, Inhibition of inducible prostaglandin E2 synthase by 15-deoxy-??12,14-prostaglandin J2 and polyunsaturated fatty acids, Biochemical Pharmacology, vol.63, issue.6, pp.1183-1189, 2002.
DOI : 10.1016/S0006-2952(02)00844-4

K. Rainsford, Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide, Inflammopharmacology, vol.14, issue.3-4, pp.120-137, 2006.
DOI : 10.1007/s10787-006-1505-9

L. Rangel-castilla, S. Gopinath, and C. Robertson, Management of Intracranial Hypertension, Neurologic Clinics, vol.26, issue.2, pp.521-541, 2008.
DOI : 10.1016/j.ncl.2008.02.003

P. Rao and E. Knaus, Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond, Journal of Pharmacy & Pharmaceutical Sciences, vol.11, issue.2, pp.81-110, 2008.
DOI : 10.18433/J3T886

A. Raz, A. Wyche, N. Siegel, and P. Needleman, Regulation of fibroblast cyclooxygenase synthesis by interleukin-1, J Biol Chem, vol.263, pp.3022-3028, 1988.

P. Reilly, The impact of neurotrauma on society: an international perspective, Prog Brain Res, vol.161, pp.3-9, 2007.
DOI : 10.1016/S0079-6123(06)61001-7

E. Reiter, L. Dinardo, and R. Costanzo, Effects of head injury on olfaction and taste, Otolaryngologic Clinics of North America, vol.37, issue.6, pp.1167-1184, 2004.
DOI : 10.1016/j.otc.2004.06.005

L. Rochat, C. Beni, J. Billieux, P. Azouvi, J. Annoni et al., Assessment of impulsivity after moderate to severe traumatic brain injury, Neuropsychological Rehabilitation, vol.8, issue.5, pp.778-797, 2010.
DOI : 10.1097/01.nmd.0000180777.41295.65

L. Rochat, X. Delbeuck, J. Billieux, M. Acremont, A. Van-der-linden et al., Assessing Impulsivity Changes in Alzheimer Disease, Alzheimer Disease & Associated Disorders, vol.22, issue.3, pp.278-283, 2008.
DOI : 10.1097/WAD.0b013e318166d692

J. Rogers and C. Read, Psychiatric comorbidity following traumatic brain injury, Brain Injury, vol.27, issue.13-14, pp.1321-1333, 2007.
DOI : 10.1080/02699050210128861

P. Roth and K. Farls, Pathophysiology of Traumatic Brain Injury, Critical Care Nursing Quarterly, vol.23, issue.3, pp.14-25, 2000.
DOI : 10.1097/00002727-200011000-00003

A. Sapirstein, H. Saito, S. Texel, T. Samad, O. Leary et al., Cytosolic phospholipase A 2 alpha regulates induction of brain cyclooxygenase-2 in a mouse model of inflammation

O. Schmidt, C. Heyde, W. Ertel, and P. Stahel, Closed head injury???an inflammatory disease?, Brain Research Reviews, vol.48, issue.2, pp.388-399, 2005.
DOI : 10.1016/j.brainresrev.2004.12.028

J. Schwab, T. Beiter, J. Linder, S. Laufer, J. Schulz et al., COX-3--a virtual pain target in humans?, The FASEB Journal, vol.17, issue.15, pp.2174-2175, 2003.
DOI : 10.1096/fj.03-0595lte

J. Schwab, H. Schluesener, and S. Laufer, COX-3: just another COX or the solitary elusive target of paracetamol?, The Lancet, vol.361, issue.9362, pp.981-982, 2003.
DOI : 10.1016/S0140-6736(03)12841-3

J. Schwab, R. Beschorner, R. Meyermann, F. Gözalan, and H. Schluesener, Persistent accumulation of cyclooxygenase-1???expressing microglial cells and macrophages and transient upregulation by endothelium in human brain injury, Journal of Neurosurgery, vol.96, issue.5, pp.892-899, 2002.
DOI : 10.3171/jns.2002.96.5.0892

N. Sehgal, V. Agarwal, R. Valli, S. Joshi, L. Antonovic et al., Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation, Biochemical Pharmacology, vol.82, issue.1, pp.53-64, 2011.
DOI : 10.1016/j.bcp.2011.03.025

K. Sekar and K. Corff, Treatment of patent ductus arteriosus: indomethacin or ibuprofen?, Journal of Perinatology, vol.79, pp.60-62, 2008.
DOI : 10.1542/peds.2005-1528

S. Shaftel, J. Olschowka, S. Hurley, A. Moore, O. Banion et al., COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells, Molecular Brain Research, vol.119, issue.2, pp.213-215, 2003.
DOI : 10.1016/j.molbrainres.2003.09.006

N. Shrestha-palikhe, S. Kim, H. Jin, E. Hwang, Y. Nam et al., Genetic Mechanisms in Aspirin-Exacerbated Respiratory Disease, Journal of Allergy, vol.60, issue.3, p.794890, 2012.
DOI : 10.1007/s10875-008-9190-7

J. Silver, T. Mcallister, and D. Arciniegas, Depression and Cognitive Complaints Following Mild Traumatic Brain Injury, American Journal of Psychiatry, vol.166, issue.6, pp.653-661, 2009.
DOI : 10.1176/appi.ajp.2009.08111676

D. Simmons, Variants of cyclooxygenase-1 and their roles in medicine, Thrombosis Research, vol.110, issue.5-6, pp.265-268, 2003.
DOI : 10.1016/S0049-3848(03)00380-3

E. Siopi, S. Calabria, M. Plotkine, C. Marchand-leroux, and M. Jafarian-tehrani, Minocycline Restores Olfactory Bulb Volume and Olfactory Behavior after Traumatic Brain Injury in Mice, Journal of Neurotrauma, vol.29, issue.2, pp.354-361, 2012.
DOI : 10.1089/neu.2011.2055

E. Siopi, G. Llufriu-dabén, F. Fanucchi, M. Plotkine, C. Marchand-leroux et al., Evaluation of late cognitive impairment and anxiety states following traumatic brain injury in mice: The effect of minocycline, Neuroscience Letters, vol.511, issue.2, pp.110-115, 2012.
DOI : 10.1016/j.neulet.2012.01.051

E. Siopi, A. Cho, S. Homsi, N. Croci, M. Plotkine et al., Minocycline Restores sAPP?? Levels and Reduces the Late Histopathological Consequences of Traumatic Brain Injury in Mice, Journal of Neurotrauma, vol.28, issue.10, pp.2135-2143, 2011.
DOI : 10.1089/neu.2010.1738

J. Spaethling, D. Geddes-klein, W. Miller, C. Von-reyn, P. Singh et al., Linking impact to cellular and molecular sequelae of CNS injury: Modeling in vivo complexity with in vitro simplicity, Prog Brain Res, vol.161, pp.27-39, 2007.
DOI : 10.1016/S0079-6123(06)61003-0

A. Spector, Arachidonic acid cytochrome P450 epoxygenase pathway, The Journal of Lipid Research, vol.50, issue.Supplement, pp.52-56, 2009.
DOI : 10.1194/jlr.R800038-JLR200

K. Statler, H. Alexander, V. Vagni, R. Holubkov, C. Dixon et al., Isoflurane exerts neuroprotective actions at or near the time of severe traumatic brain injury, Brain Research, vol.1076, issue.1, pp.216-224, 2006.
DOI : 10.1016/j.brainres.2005.12.106

M. Stiefel, A. Shaner, and S. Schaefer, The Edwin Smith Papyrus: The Birth of Analytical Thinking in Medicine and Otolaryngology, The Laryngoscope, vol.14, issue.2, pp.182-188, 2006.
DOI : 10.1097/01.mlg.0000191461.08542.a3

N. Stocchetti, A. Colombo, F. Ortolano, W. Videtta, R. Marchesi et al., Time Course of Intracranial Hypertension after Traumatic Brain Injury, Journal of Neurotrauma, vol.24, issue.8, pp.1339-1346, 2007.
DOI : 10.1089/neu.2007.0300

K. Strauss, COX2 inhibitors for acquired brain injuries: Is the time ripe?*, Critical Care Medicine, vol.38, issue.2, pp.723-724, 2010.
DOI : 10.1097/CCM.0b013e3181bc80b9

K. Strauss, Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain, Brain, Behavior, and Immunity, vol.22, issue.3, pp.285-298, 2008.
DOI : 10.1016/j.bbi.2007.09.011

K. Strauss, M. Barbe, R. Marshall, R. Raghupathi, S. Mehta et al., Prolonged Cyclooxygenase-2 Induction in Neurons and Glia Following Traumatic Brain Injury in the Rat, Journal of Neurotrauma, vol.17, issue.8, pp.695-711, 2000.
DOI : 10.1089/089771500415436

H. Süleyman, B. Demircan, and Y. Karagöz, Anti-inflammatory and side effects of cyclooxygenase inhibitors, Pharmacol Rep, vol.59, pp.247-258, 2007.

Y. Surh, H. Na, J. Park, H. Lee, W. Kim et al., 15-Deoxy-??12,14-prostaglandin J2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling, Biochemical Pharmacology, vol.82, issue.10, pp.1335-1351, 2011.
DOI : 10.1016/j.bcp.2011.07.100

F. Tagliaferri, C. Compagnone, M. Korsic, F. Servadei, and J. Kraus, A systematic review of brain injury epidemiology in Europe, Acta Neurochirurgica, vol.8, issue.s, pp.255-268, 2006.
DOI : 10.1007/s00701-005-0651-y

T. Tanioka, Y. Nakatani, N. Semmyo, M. Murakami, and I. Kudo, Molecular Identification of Cytosolic Prostaglandin E2 Synthase That Is Functionally Coupled with Cyclooxygenase-1 in Immediate Prostaglandin E2Biosynthesis, Journal of Biological Chemistry, vol.275, issue.42, pp.32775-32782, 2000.
DOI : 10.1074/jbc.M003504200

G. Teasdale and B. Jennett, Assessment of coma and impaired consciousness. A practical scale, Lancet, vol.2, pp.81-84, 1974.

I. Tegeder, J. Pfeilschifter, and G. Geisslinger, Cyclooxygenase-independent actions of cyclooxygenase inhibitors, The FASEB Journal, vol.15, issue.12, pp.2057-2072, 2001.
DOI : 10.1096/fj.01-0390rev

N. Terpolilli, K. Zweckberger, R. Trabold, L. Schilling, R. Schinzel et al., The Novel Nitric Oxide Synthase Inhibitor 4-amino-tetrahydro-L-biopterine Prevents Brain Edema Formation and Intracranial Hypertension following Traumatic Brain Injury in Mice, Journal of Neurotrauma, vol.26, issue.11, pp.1963-1975, 2009.
DOI : 10.1089/neu.2008.0853

O. Thau-zuchman, E. Shohami, A. Alexandrovich, V. Trembovler, and R. Leker, The Anti-Inflammatory Drug Carprofen Improves Long-Term Outcome and Induces Gliogenesis after Traumatic Brain Injury, Journal of Neurotrauma, vol.29, issue.2, pp.375-384, 2012.
DOI : 10.1089/neu.2010.1673

F. Tomaiuolo, U. Bivona, J. Lerch, D. Paola, M. Carlesimo et al., Memory and anatomical change in severe non missile traumatic brain injury: ???1 vs. ???8years follow-up, Brain Research Bulletin, vol.87, issue.4-5, pp.373-382, 2012.
DOI : 10.1016/j.brainresbull.2012.01.008

A. Unterberg, J. Stover, B. Kress, and K. Kiening, Edema and brain trauma, Neuroscience, vol.129, issue.4, pp.1021-1029, 2004.
DOI : 10.1016/j.neuroscience.2004.06.046

J. Vane and R. Botting, The mechanism of action of aspirin, Thrombosis Research, vol.110, issue.5-6, pp.255-258, 2003.
DOI : 10.1016/S0049-3848(03)00379-7

J. Vane, Y. Bakhle, and R. Botting, CYCLOOXYGENASES 1 AND 2, Annual Review of Pharmacology and Toxicology, vol.38, issue.1, pp.97-120, 1998.
DOI : 10.1146/annurev.pharmtox.38.1.97

J. Vane, Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs, Nature New Biology, vol.231, issue.25, pp.232-235, 1971.
DOI : 10.1038/newbio231232a0

H. Vanegas and H. Schaible, Prostaglandins and cycloxygenases in the spinal cord, Progress in Neurobiology, vol.64, issue.4, pp.327-363, 2001.
DOI : 10.1016/S0301-0082(00)00063-0

R. Vink and A. Nimmo, Multifunctional drugs for head injury, Neurotherapeutics, vol.6, issue.Suppl 1, pp.28-42, 2009.
DOI : 10.1016/j.nurt.2008.10.036

M. Walker, R. Kurumbail, J. Kiefer, K. Moreland, C. Koboldt et al., A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors, Biochemical Journal, vol.357, issue.3, pp.709-718, 2001.
DOI : 10.1042/bj3570709

H. Wang and Y. Ma, Experimental models of traumatic axonal injury, Journal of Clinical Neuroscience, vol.17, issue.2, pp.157-162, 2010.
DOI : 10.1016/j.jocn.2009.07.099

Y. Wang, V. Dawson, and T. Dawson, Poly(ADP-ribose) signals to mitochondrial AIF: A key event in parthanatos, Experimental Neurology, vol.218, issue.2, pp.193-202, 2009.
DOI : 10.1016/j.expneurol.2009.03.020

Y. Wang, J. Zhao, A. Kalsotra, C. Turman, R. Grill et al., Levels after Traumatic Brain Injury, Journal of Neurotrauma, vol.25, issue.10, pp.1187-1194, 2008.
DOI : 10.1089/neu.2008.0542

T. Warner and J. Mitchell, Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum?, Proceedings of the National Academy of Sciences, vol.99, issue.21, pp.13371-13373, 2002.
DOI : 10.1073/pnas.222543099

T. Warner, F. Giuliano, I. Vojnovic, A. Bukasa, J. Mitchell et al., Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis, Proceedings of the National Academy of Sciences, vol.96, issue.13, pp.7563-7568, 1999.
DOI : 10.1073/pnas.96.13.7563

C. Werner and K. Engelhard, Pathophysiology of traumatic brain injury, British Journal of Anaesthesia, vol.99, issue.1, pp.4-9, 2007.
DOI : 10.1093/bja/aem131

D. Willoughby, A. Moore, and P. Colville-nash, COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease, The Lancet, vol.355, issue.9204, pp.646-648, 2000.
DOI : 10.1016/S0140-6736(99)12031-2

E. Wilde, S. Mccauley, T. Kelly, H. Levin, C. Pedroza et al., Feasibility of the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) in Adults, Journal of Neurotrauma, vol.27, issue.6, pp.975-981, 2010.
DOI : 10.1089/neu.2009.1193

J. Wilson, L. Pettigrew, and G. Teasdale, Structured Interviews for the Glasgow Outcome Scale and the Extended Glasgow Outcome Scale: Guidelines for Their Use, Journal of Neurotrauma, vol.15, issue.8, pp.573-585, 1998.
DOI : 10.1089/neu.1998.15.573

K. Wu, Aspirin and Salicylate : An Old Remedy With a New Twist, Circulation, vol.102, issue.17, pp.2022-2023, 2000.
DOI : 10.1161/01.CIR.102.17.2022

W. Xie, J. Chipman, D. Robertson, R. Erikson, and D. Simmons, Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing., Proceedings of the National Academy of Sciences, vol.88, issue.7, pp.2692-2696, 1991.
DOI : 10.1073/pnas.88.7.2692

X. Xu, L. Sansores-garcia, X. Chen, N. Matijevic-aleksic, M. Du et al., Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate, Proceedings of the National Academy of Sciences, vol.96, issue.9, pp.5292-5297, 1999.
DOI : 10.1073/pnas.96.9.5292

Y. Xu, S. Phipps, M. Turner, and D. Simmons, The N-terminus of COX-1 and its effect on cyclooxygenase-1 catalytic activity, Journal of Genetics and Genomics, vol.37, issue.2, pp.117-123, 2010.
DOI : 10.1016/S1673-8527(09)60030-8

M. Yin, Y. Yamamoto, and R. Gaynor, The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta, Nature, vol.396, pp.77-80, 1998.

A. Yurdakoc, I. Gunday, and D. Memi, Effects of halothane, isoflurane, and sevoflurane on lipid peroxidation following experimental closed head trauma in rats, Acta Anaesthesiologica Scandinavica, vol.98, issue.5, pp.658-663, 2008.
DOI : 10.1111/j.1399-6576.2008.01635.x

W. Zhang, I. Koerner, R. Noppens, M. Grafe, H. Tsai et al., Soluble Epoxide Hydrolase: A Novel Therapeutic Target in Stroke, Journal of Cerebral Blood Flow & Metabolism, vol.25, issue.12, pp.1931-1940, 2007.
DOI : 10.1152/ajprenal.00165.2003

W. Zhang, H. Hu, L. Zhang, W. Ding, H. Yao et al., Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors, Neuroscience Letters, vol.363, issue.3, pp.247-251, 2004.
DOI : 10.1016/j.neulet.2004.03.088